BlackRock
DERM icon

BlackRock’s Journey Medical DERM Stock Holding History

BlackRock’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.56M Buy
972,862
+253,078
+35% +$1.96M ﹤0.01% 3868
2025
Q4 		$5.55M Buy
719,784
+86,725
+14% +$680K ﹤0.01% 3793
2025
Q3 		$4.51M Buy
633,059
+88,717
+16% +$644K ﹤0.01% 3819
2025
Q2 		$3.91M Buy
544,342
+491,108
+923% +$3.39M ﹤0.01% 3865
2025
Q1 		$314K Buy
53,234
+492
+0.9% +$2.42K ﹤0.01% 4516
2024
Q4 		$206K Buy
52,742
+124
+0.2% +$678 ﹤0.01% 4616
2024
Q3 		$297K Buy
52,618
+754
+1% +$3.88K ﹤0.01% 4443
2024
Q2 		$293K Buy
51,864
+2,455
+5% +$10.1K ﹤0.01% 4469
2024
Q1 		$182K Buy
49,409
+5,517
+13% +$24K ﹤0.01% 4608
2023
Q4 		$253K Buy
43,892
+29,500
+205% +$131K ﹤0.01% 4580
2023
Q3 		$39.4K Sell
14,392
-609
-4% -$1.36K ﹤0.01% 5042
2023
Q2 		$23.9K Buy
15,001
+6,273
+72% +$10.1K ﹤0.01% 5185
2023
Q1 		$13.7K Buy
8,728
+282
+3% +$526 ﹤0.01% 5296
2022
Q4 		$16.2K Buy
8,446
+188
+2% +$372 ﹤0.01% 5398
2022
Q3 		$21K Sell
8,258
-235
-3% -$801 ﹤0.01% 5499
2022
Q2 		$32K Sell
8,493
-141
-2% -$558 ﹤0.01% 5489
2022
Q1 		$41K Sell
8,634
-694
-7% -$3.46K ﹤0.01% 5451
2021
Q4 		$50K Buy
+9,328
New +$67.6K ﹤0.01% 5401

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

BlackRock's DERM Position: Q1 2026 in Review

BlackRock increased its Journey Medical (DERM) stake by 35% in Q1 2026, buying an estimated $1.96M and bringing the position to 972,862 shares worth $4.56M. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

BlackRock first reported a position in DERM in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.55M in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • BlackRock held 972,862 shares of Journey Medical worth $4.56M as of Q1 2026.
  • BlackRock bought 253,078 Journey Medical shares in Q1 2026, an estimated $1.96M.
  • Journey Medical made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3868 holding.
  • BlackRock first reported a position in Journey Medical in Q4 2021 and has held it in 18 quarters since.
  • BlackRock's Journey Medical position peaked at $5.55M in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.